yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q37470350-303773B1-0841-4076-BCD9-99C9A562066D
Q37470350-303773B1-0841-4076-BCD9-99C9A562066D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37470350-303773B1-0841-4076-BCD9-99C9A562066D
Lack of reduction in buprenorphine injection after introduction of co-formulated buprenorphine/naloxone to the Malaysian market.
P2860
Q37470350-303773B1-0841-4076-BCD9-99C9A562066D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37470350-303773B1-0841-4076-BCD9-99C9A562066D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c04df39dc199b5d7a505a0e0095ab0d1884c3b7d
P2860
Bioavailability of sublingual buprenorphine.